Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects
Alzheimer's and Parkinson's diseases are two of the most frequent neurological diseases. The clinical features of AD are memory decline and cognitive dysfunction, while PD mainly manifests as motor dysfunction such as limb tremors, muscle rigidity abnormalities, and slow gait. Abnormalities in chole...
保存先:
| 主要な著者: | , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2024-06-01
|
| シリーズ: | Neurobiology of Disease |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S0969996124001049 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|